The FDA has issued an advisory to prescribers of the risk of QT prolongation with ondansetron. It should be avoided in patients with prolonged QT, and used cautiously in patients on other QT prolonging drugs (abstract)
Archives
Categories
- Cardiology (248)
- GI (122)
- Hematology and Oncology (158)
- ID (245)
- Influenza (39)
- Neurology (85)
- Other (237)
- Peri-Operative Medicine (90)
- Pulmonary and Critical Care (176)
- Renal (31)
Quick Links
Meta